Literature DB >> 9433486

Antithrombin. A bloody important serpin.

I Björk1, S T Olson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9433486

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  28 in total

1.  Anti-thrombin is expressed in the benign prostatic epithelium and in prostate cancer and is capable of forming complexes with prostate-specific antigen and human glandular kallikrein 2.

Authors:  Yue Cao; Ake Lundwall; Virgil Gadaleanu; Hans Lilja; Anders Bjartell
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

Review 2.  Intracellular proteoglycans.

Authors:  Svein Olav Kolset; Kristian Prydz; Gunnar Pejler
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

3.  Hemostatic agents of broad applicability produced by selective tuning of factor Xa zymogenicity.

Authors:  Lacramioara Ivanciu; Rodney M Camire
Journal:  Blood       Date:  2015-04-20       Impact factor: 22.113

4.  Zymogen-like factor Xa variants restore thrombin generation and effectively bypass the intrinsic pathway in vitro.

Authors:  Matthew W Bunce; Raffaella Toso; Rodney M Camire
Journal:  Blood       Date:  2010-09-23       Impact factor: 22.113

5.  An anticoagulant RNA aptamer that inhibits proteinase-cofactor interactions within prothrombinase.

Authors:  Sai K Buddai; Juliana M Layzer; Genmin Lu; Christopher P Rusconi; Bruce A Sullenger; Dougald M Monroe; Sriram Krishnaswamy
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

Review 6.  Recent advances in the discovery and development of factor XI/XIa inhibitors.

Authors:  Rami A Al-Horani; Daniel K Afosah
Journal:  Med Res Rev       Date:  2018-05-04       Impact factor: 12.944

7.  On designing non-saccharide, allosteric activators of antithrombin.

Authors:  Arjun Raghuraman; Aiye Liang; Chandravel Krishnasamy; Trish Lauck; Gunnar T Gunnarsson; Umesh R Desai
Journal:  Eur J Med Chem       Date:  2008-10-09       Impact factor: 6.514

8.  Detection and characterisation of large SERPINC1 deletions in type I inherited antithrombin deficiency.

Authors:  Véronique Picard; Jian-Min Chen; Brigitte Tardy; Marie-Françoise Aillaud; Christine Boiteux-Vergnes; Marie Dreyfus; Joseph Emmerich; Cécile Lavenu-Bombled; Ulrike Nowak-Göttl; Nathalie Trillot; Martine Aiach; Martine Alhenc-Gelas
Journal:  Hum Genet       Date:  2009-09-17       Impact factor: 4.132

9.  A novel allosteric pathway of thrombin inhibition: Exosite II mediated potent inhibition of thrombin by chemo-enzymatic, sulfated dehydropolymers of 4-hydroxycinnamic acids.

Authors:  Brian L Henry; Bernhard H Monien; Paul E Bock; Umesh R Desai
Journal:  J Biol Chem       Date:  2007-09-05       Impact factor: 5.157

10.  Capillary electrophoretic study of small, highly sulfated, non-sugar molecules interacting with antithrombin.

Authors:  Aiye Liang; Arjun Raghuraman; Umesh R Desai
Journal:  Electrophoresis       Date:  2009-05       Impact factor: 3.535
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.